Nastech Pharmaceutical Company, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Nastech Pharmaceutical Company, Inc. makes
Nastech Pharmaceutical Company, Inc. produces diagnostic devices for breast cancer screening, including the Mammary Aspiration Specimen Cytology Test (MASCT) and the Mammary Aspiration Specimen Cytology Test, which analyze fluid samples from breast aspirates for cytological examination.
These devices are classified as Class II under FDA regulations and are listed via the 510(k) pathway. The company is based in the United States.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Mammary Aspiration Specimen Cytology Test Ref K030443
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Nastech Pharmaceutical Company, Inc. have in the registry?
The registry currently lists 2 devices for Nastech Pharmaceutical Company, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Nastech Pharmaceutical Company, Inc.'s devices?
Among its 2 most recently registered devices, Nastech Pharmaceutical Company, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Nastech Pharmaceutical Company, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Nastech Pharmaceutical Company, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Nastech Pharmaceutical Company, Inc. in the registry?
The most recently registered devices listed for Nastech Pharmaceutical Company, Inc. include NASTECH MAMMARY ASPIRATION SPECIMAN CYTOLOGY TEST MASCT and MAMMARY ASPIRATION SPECIMEN CYTOLOGY TEST.